NEWS | alsv | Page 2 of 16

Companies in the News

Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of GRANITE

Paper reports that Gritstone’s tumor-specific, neoantigen vaccination approach drives priming and boosting of tumor-specific T cells,...

Gritstone Announces Updated Overall Survival Results in CRC Patients from Phase 1/2 Study of GRANITE

Overall survival (OS) for patients with metastatic, microsatellite stable colorectal cancer (MSS-CRC) who had two prior lines of therapy...

Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform

SOMERVILLE, Mass.--(BUSINESS WIRE)--Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known...

Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing

Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by...

eFFECTOR Therapeutics Provides Pipeline and Business Updates

Tomivosertib development strategy updated, including addition of a new cohort in Phase 2b KICKSTART trial in non-small cell lung cancer...

Nuvation Bio Announces FDA Clearance of IND Application for NUV-868 for the Advanced Solid Tumors

NEW YORK, Jan. 20, 2022 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet...

Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs

Amgen wants its future drugs to be multispecific, and so the biopharmaceutical company selected Generate Biomedicines for a $1.9 billion...

Landus and Indigo Join Forces to Elevate Farmers’ Profitable Role in Digital Ag Landscape

Landus farmers will gain access to new carbon revenue stream and digital grain marketing tools AMES, Iowa (December 2, 2021) – Landus,...

Generate Biomedicines Announces Raise of $370 Million to Advance its Drug Generation Platform

Cambridge, Mass, November 18, 2021 – Generate Biomedicines, whose machine learning-powered Generative Biology platform can rapidly invent...